GSN
protein-codinggelsolin, the group of Gelsolin/villins
Gene summary
The protein encoded by this gene binds to the "plus" ends of actin monomers and filaments to prevent monomer exchange. The encoded calcium-regulated protein functions in both assembly and disassembly of actin filaments. Defects in this gene are a cause of familial amyloidosis Finnish type (FAF). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~125.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007097
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0007097
Submitter: G2P
Inheritance Pattern: SD
Disease ID:MONDO:0007097
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007097
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007097
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Dermatologic; Neurologic; Ophthalmologic; Renal
Intervention: Cardiovascular
Rationale: Individuals with cardiac conduction disease have been described, and surveillance (eg, with electocardiogram) may allow early management (eg, with pacemaker)
Comments: Recessive disease has been reported as resulting in a more severe phenotype
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GSN variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_198252.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 178 | 1 | 187 | ||
| missense | 3 | 3 | 375 | 58 | 4 | 443 |
| nonsense | 10 | 10 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 19 | 19 | ||||
| splice donor/acceptor (+/-2bp) | 19 | 1 | 20 | |||
| Total | 3 | 3 | 432 | 237 | 5 | 680 |
Highest pathogenic variant AF is 0.0000049566665
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_937895.1 | 16 | MANE Select | |
| Ensembl | ENSP00000404226.2 | 16 | MANE Select | |
| RefSeq | NP_000168.1 | 17 | Standard | |
| RefSeq | NP_001121134.1 | 16 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Fc gamma R-mediated phagocytosis - Homo sapiens (human)
- Regulation of actin cytoskeleton - Homo sapiens (human)
- Viral carcinogenesis - Homo sapiens (human)
- Regulation of Actin Cytoskeleton
- Senescence and Autophagy in Cancer
Biological Process
- phagocytosis, engulfment
- aging
- positive regulation of gene expression
- oligodendrocyte development
- striated muscle atrophy
Molecular Function
- actin binding
- calcium ion binding
- protein binding
- myosin II binding
- actin filament binding
Cellular Component
- ruffle
- podosome
- extracellular region
- extracellular space
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000373818
- Coding exons
- 17
- Length
- 125050
- Individuals with no LoFs
- 125664
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 84
- Defined
- 125748
- p
- 0.000334
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.962 | 401 | 459 | 0.874 | 0.0000308 | 5034 |
| Missense (PolyPhen) | 156 | 189.86 | 0.82167 | 2090 | ||
| Synonymous | 0.427 | 189 | 197 | 0.961 | 0.0000146 | 1604 |
| Loss of Function | 2.37 | 23 | 38.9 | 0.591 | 0.00000190 | 433 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00046 | 0.00046 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00060 | 0.00060 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00037 | 0.00037 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Calcium-regulated, actin-modulating protein that binds to the plus (or barbed) ends of actin monomers or filaments, preventing monomer exchange (end-blocking or capping). It can promote the assembly of monomers into filaments (nucleation) as well as sever filaments already formed. Plays a role in ciliogenesis. {ECO:0000269|PubMed:20393563}.;
- Disease
- DISEASE: Amyloidosis 5 (AMYL5) [MIM:105120]: A hereditary generalized amyloidosis due to gelsolin amyloid deposition. It is typically characterized by cranial neuropathy and lattice corneal dystrophy. Most patients have modest involvement of internal organs, but severe systemic disease can develop in some individuals causing peripheral polyneuropathy, amyloid cardiomyopathy, and nephrotic syndrome leading to renal failure. {ECO:0000269|PubMed:1338910, ECO:0000269|PubMed:2176481}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.752
Intolerance Scores
- LoFtool
- 0.888
- RVIS EVS
- 0.61
- RVIS percentile EVS
- 82.94
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.981
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |